We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current RPRX market cap is 16.72B. The company's latest EPS is USD 1.8995 and P/E is 14.72.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 617.71M | 467.76M | 683.97M | 653.4M | 543.61M |
| Operating Income | 233.2M | 28.33M | 513.58M | 363.27M | 153.52M |
| Net Income | 142.65M | -456.08M | 340.76M | 227.63M | 72.11M |
| Year End December 30 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 2.12B | 2.29B | 2.24B | 2.35B |
| Operating Income | -13.79M | 1.64B | 1.41B | 913.92M | 1.5B |
| Net Income | 51.28M | 975.04M | 619.73M | 42.83M | 1.13B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 17.67B | 16.81B | 17.07B | 17.12B | 15.86B |
| Total Liabilities | 7.26B | 7.29B | 7.25B | 7.31B | 6.27B |
| Total Equity | 10.42B | 9.53B | 9.82B | 9.81B | 9.59B |
| Year End December 30 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 15.07B | 16.02B | 17.52B | 16.81B | 16.38B |
| Total Liabilities | 10.03M | 6.12B | 7.27B | 7.29B | 6.3B |
| Total Equity | 15.06B | 9.9B | 10.25B | 9.53B | 10.08B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 1.57B | 2.14B | 1.03B | 1.64B | 2.22B |
| Investing | -1.44B | -1.03B | -558.53M | -621.96M | -1.07B |
| Financing | -679.31M | -944.86M | -210.37M | -557.37M | -1.92B |
| Year End December 30 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 45.61M | 2.03B | 2.02B | 2.14B | 2.99B |
| Investing | -1.87B | -2.76B | -1.87B | -1.03B | -2.07B |
| Financing | 1.91B | 1.49B | 385.11M | -944.86M | -2.15B |
| Market Cap | 16.72B |
| Price to Earnings Ratio | 14.72 |
| Price to Sales Ratio | 7.1 |
| Price to Cash Ratio | 35.03 |
| Price to Book Ratio | 1.66 |
| Dividend Yield | 2.89% |
| Shares Outstanding | 597.43M |
| Average Volume (1 week) | 2.72M |
| Average Volume (1 Month) | 2.6M |
| 52 Week Change | -22.54% |
| 52 Week High | 36.19 |
| 52 Week Low | 25.92 |
| Spread (Intraday) | 0.89 (3.15%) |
| Company Name | Royalty Pharma PLC |
| Address |
the pavilions bridgwater road bristol BS13 8AE |
| Website | https://www.royaltypharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
